Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer

Journal of the American Society of Echocardiography

Volumn 27, Issue 1, 2014, Pages 83-92

  Florescu, Maria ^a   Magda, Lucia Stefania ^a   Enescu, Oana Aurelia ^a   Jinga, Dan ^a   Vinereanu, Dragos ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Epirubicin induced cardiotoxicity; Myocardial deformation and rotation; Speckle tracking echocardiography

Indexed keywords

DOXORUBICIN; EPIRUBICIN;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; FEMALE; GEOMETRY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HUMAN; MIDDLE AGED; MULTIPLE CYCLE TREATMENT;

EF; EJECTION FRACTION; EPIRUBICIN-INDUCED CARDIOTOXICITY; FRACTIONAL SHORTENING; FS; HEART FAILURE; HF; LEFT VENTRICULAR; LONGITUDINAL STRAIN; LONGITUDINAL STRAIN RATE; LS; LSR; LV; MYOCARDIAL DEFORMATION AND ROTATION; RECEIVER OPERATING CHARACTERISTIC; ROC; SPECKLE-TRACKING ECHOCARDIOGRAPHY; STE; TISSUE VELOCITY IMAGING; TVI;

ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELASTICITY IMAGING TECHNIQUES; EPIRUBICIN; FEMALE; HUMANS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84896529531     PISSN: 08947317     EISSN: 10976795     Source Type: Journal    
DOI: 10.1016/j.echo.2013.10.008     Document Type: Article

References (45)

1. World Health Organization. Breast cancer: prevention and control. Available at: http://www.who.int/cancer/detection/breastcancer/en/. Accessed October 31, 2013.
2. J.R. Walker, A. Sharma, M. Lytwyn, S. Bohonis, J. Thliveris, and P.K. Singal et al. The cardioprotective role of probucol against anthracycline and trastuzumab-mediated cardiotoxicity J Am Soc Echocardiogr 24 2011 699 705
3. D. Cardinale, A. Colombo, G. Lamantia, N. Colombo, M. Civelli, and G. De Giacomi et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy J Am Coll Cardiol 55 2010 213 220
4. L. Oreto, M.C. Todaro, M.M. Umland, C. Kramer, R. Qamar, and S. Carerj et al. Use of echocardiography to evaluate the cardiac effects of therapies used in cancer treatment: what do we know? J Am Soc Echocardiogr 25 2012 1141 1152
5. G. Mercuro, C. Cadeddou, A. Piras, M. Dessì, C. Madeddu, and M. Deidda et al. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers The Oncologist 12 2007 1124 1233
6. R.S. Jiji, C.M. Kramer, and M. Salerno Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs J Nucl Cardiol 19 2012 377 388
7. A. Albini, G. Pannesi, F. Donatelli, R. Cammarota, S. De Flora, and D.M. Noonan Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention J Natl Cancer Inst 102 2010 14 25
8. M.S. Ewer, M.K. Ali, B. Mackay, S. Wallace, M. Valdivieso, and S.S. Legha et al. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving adriamycin J Clin Oncol 2 1984 112 117
9. H. Sawaya, I.A. Sebag, J.C. Plana, J.L. Januzzi, B. Ky, and V. Cohen et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients Am J Cardiol 107 2011 1375 1380
10. A. Seidman, C. Hudis, M.K. Pierri, S. Shak, V. Paton, and M. Ashby et al. Cardiac dysfunction in the trastuzumab clinical trials experience J Clin Oncol 20 2002 1215 1221
11. C.M. Yu, J.E. Sanderson, T.H. Marwick, and J.K. Oh Tissue Doppler imaging: a new prognosticator for cardiovascular disease J Am Coll Cardiol 49 2007 1903 1914
12. M. Dessì, C. Madeddu, A. Piras, C. Cadeddu, G. Antoni, and G. Mercuro et al. Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate Springerplus 2 2013 198
13. J.L. Hare, J.K. Brown, R. Leano, C. Jenkins, N. Woodward, and T.H. Marwick Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab Am Heart J 158 2009 294 301
14. E. Ho, A. Brown, P. Barrett, R.B. Morgan, G. King, and M.J. Kennedy et al. Subclinical anthracycline- and trastuzumab- induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study Heart 96 2010 701 707
15. S. Tassan-Mangina, D. Codorean, M. Metivier, B. Costab, C. Himberlinc, and C. Jouannaudb et al. Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alteration of left ventricular function during a prospective study Eur J Echocardiography 7 2006 141 146
16. M. Leitman, P. Lysyansky, S. Sidenko, V. Shir, E. Peleg, and M. Binenbaum et al. Two-dimensional strain - a novel software for real-time quantitative echocardiographic assessment of myocardial function J Am Soc Echocardiogr 17 2004 1021 1029
17. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, and P.A. Pellikka et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
18. B.H. Amundsen, T. Helle-Valle, T. Edvardsen, H. Torp, J. Crosby, and E. Lyseggen et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged resonance imaging J Am Coll Cardiol 47 2006 789 793
19. P.P. Sengupta, A.J. Tajik, K. Chandrasekaran, and B.K. Khandheria Twist mechanics of the left ventricle: principles and application JACC Cardiovasc Imaging 1 2008 366 376
20. Y. Notomi, Z.B. Popovic, H. Yamada, D.W. Wallick, M.G. Martin, and S. Oryszak et al. Ventricular untwisting: a temporal link between left ventricular relaxation and suction Am J Physiol Heart Circ Physiol 294 2008 505 513
21. P. Thavendiranathan, A.D. Grant, T. Negishi, J.C. Plana, Z.B. Popović, and T.H. Marwick Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy J Am Coll Cardiol 61 2013 77 84
22. J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 1986 307 310
23. D. Vinereanu, A. Khokhar, and A.G. Fraser Reproducibility of pulsed wave tissue Doppler echocardiography J Am Soc Echocardiogr 12 1999 492 499
24. A.D. Margulescu, R.C. Rimbas, M. Florescu, R.E. Dulgheru, M. Cinteza, and D. Vinereanu Cardiac adaptation in acute hypertensive pulmonary edema Am J Cardiol 109 2012 1472 1481
25. X. Zhou, N.A. Obuchowski, and D.K. McClish Statistical methods in diagnostic medicine 2002 John Wiley New York
26. National Cancer Institute. NCI dictionary of cancer terms. Available at: www.cancer.gov/dictionary/. Accessed October 31, 2013.
27. M. Martín, J.F. Esteva, E. Alba, B. Khandheria, L. Pérez-Isla, and J.A. García-Sáenz et al. Minimizing cardiotoxicity while optimizing treatment efficacy with trastuzumab: review and expert recommendations Oncologist 14 2009 1 11
28. A. Dolci, R. Dominici, D. Cardinale, M.T. Sandri, and M. Panteghini Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use Am J Clin Pathol 130 2008 688 695
29. R.L. Jones, C. Swanton, and M.S. Ewer Anthracycline cardiotoxicity Expert Opin Drug Saf 5 2006 791 809
30. S. Gluck Adjuvant chemotherapy for early breast cancer: optimal use of epirubicin Oncologist 10 2005 780 791
31. R. Jurcut, H. Wildiers, J. Ganame, J. D'hooge, R. Paridaens, and J.U. Voigt Detection and monitoring of cardiotoxicity - what does modern cardiology offer? Support Care Cancer 16 2008 437 445
32. E.T. Yeh, and C.L. Bickford Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis and management J Am Coll Cardiol 53 2009 2231 2247
33. I. Brana, and J. Tabernero Cardiotoxicity Ann Oncol 21 2010 173 179
34. M. Ryberg, D. Nielsen, T. Skovsgaard, J. Hansen, B.V. Jensen, and P. Dombernowsky Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer J Clin Oncol 16 1998 3502 3508
35. X. Bi, Y. Deng, F. Zeng, Y. Zhu, Y. Wu, and C. Zhao et al. Evaluation of epirubicin-induced cardiotoxicity by two-dimensional strain echocardiography in breast cancer patients J Huazhong Univ Sci Technolog Med Sci 29 2009 39 44
36. J.M. Appel, P. Sogaard, C.E. Mortensen, K. Skagen, and D.L. Nielsen Tissue-Doppler assessment of cardiac left ventricular function during short-term adjuvant epirubicin therapy for breast cancer J Am Soc Echocardiogr 24 2011 200 206
37. M. Lotrionte, G. Palazzoni, R. Natali, G. Comerci, A. Abbate, and F. Loperfido et al. Assessment of left ventricular systolic dysfunction by tissue Doppler imaging to detect subclinical cardiomyopathy early after anthracicline therapy Minerva Cardioangiol 55 2007 711 720
38. M. Becker, E. Bilke, H. Kuhl, M. Katoh, R. Kramann, and A. Franke et al. Analysis of myocardial deformation based on pixel tracking in two-dimensional echocardiographic images enables quantitative assessment of regional left ventricular function Heart 92 2006 1102 1108
39. J.T. Poterucha, S. Kutty, R.K. Lindquist, L. Li, and B.W. Eidem Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction J Am Soc Echocardiogr 25 2012 733 740
40. T. Yingchoncharoen, S. Agarwal, Z.B. Popović, and T.H. Marwick Normal ranges of left ventricular strain: a meta-analysis J Am Soc Echocardiogr 26 2013 185 191
41. T. Halle-Valle, J. Crosby, T. Edvardsen, E. Lyseggen, B.H. Amundsen, and H.J. Smith et al. Non-invasive method for assessment of left ventricular rotation: speckle tracking echocardiography Circulation 112 2005 3149 3156
42. M. Takeuchi, H. Nakai, M. Kokumai, T. Nishikage, S. Otani, and R.M. Lang Age related changes in left ventricular twist assessed by two-dimensional speckle-tracking imaging J Am Soc Echocardiography 19 2006 1077 1084
43. H. Motoki, J. Koyama, H. Nakazawa, K. Aizawa, H. Kasai, and A. Izawa et al. Torsion analysis in the early detection of anthraycline-mediated cardiomyopathy Eur Heart J Cardiovasc Imaging 13 2012 95 103
44. D. Vinereanu, C.F. Mädler, C. Gherghinescu, A.O. Ciobanu, and A.G. Fraser Cumulative impact of cardiovascular risk factors on regional left ventricular function and reserve: progressive long-axis dysfunction with compensatory radial changes Echocardiography 28 2011 813 820
45. N. Fallah-Rad, J.R. Walker, A. Wassef, M. Lytwyn, S. Bohonis, and T. Fang et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy J Am Coll Cardiol 57 2011 2263 2270